Using next generation sequencing (NGS), they found that the frequency of mutations in STAT3/STAT5b was 39% in patients with LGLL alone and 15% in patients with a concomitant diagnosis of MDS-LGLL. The gene discussed is STAT3; the disease is T-cell large granular lymphocyte leukemia.